CLL at the Forefront of Precision Medicine
Chronic lymphocytic leukemia (CLL) represents a paradigmatic disease for the implementation of precision medicine approaches aimed at improving patient care.
This meeting brings together a diverse audience of scientists, including clinical investigators and diagnosticians, to discuss with international faculty the latest developments in the field while also sharing experiences.
The scientific programme and hands-on workshops have been designed to encourage discussion, exchange of knowledge, and collaboration.
Day 1, Thursday, October 15
| 13:30 – 13:45 / Auditorium |
Welcome
Paolo Ghia |
| 13:45 – 14:30 / Auditorium |
Plenary talk The genomic landscape of CLL: is there anything left to discover?
Moderator
Speaker |
| 14:30 – 15:15 / Auditorium |
Discussion Gene deregulation in CLL
Moderator
Discussants |
| 15:15 – 15:45 | Coffee break |
| 15:45 – 17:00 / Auditorium |
Session I Biomarker-guided management of CLL
Moderators
Discussants |
| 17:00 – 17:20 | Coffee break |
| 17:20 – 18.40 / Auditorium |
Session II The global community of CLL
Moderators
Discussants |
| 18.40 – 19.40 | Welcome Reception |
Day 2, Friday, October 16
| 08:30 – 09:15 / Auditorium |
Plenary talk Dangerous liasons: the tumor microenvironment in CLL
Moderator
Speaker |
| 09:15 – 10:00 / Auditorium |
Discussion What is CLL?
Moderator
Discussants |
| 10:00 – 10:30 | Coffee break |
| 10:30 – 12:00 / Auditorium |
Session III How do I treat CLL in 2026?
Moderators
Discussants |
| 12:00 – 13:00 | Lunch break |
| 13:00 – 14:30 |
Workshops – Rotation A
Workshop I – Auditorium
Moderators Panagiotis Baliakas, Sarka Pospisilova
Workshop II – Room A1
Moderators Anastasia Chatzidimitriou, Frederic Davi
Workshop III – Room A2–A3
Moderators Arnon Kater, Andy Rawstron
Workshop IV – Room A4
Moderators Christina Karamanidou, Kostas Stamatopoulos
Workshop V – Room South 9–10
Moderators Tamar Tadmor, Andrea Visentin
Workshop VI – Room South 11–12
Moderators Daniela Alves, Carsten Utoft Niemann |
| 14:30 – 14:45 | Coffee break |
| 14:45 – 16:00 / Auditorium |
Session IV: Targeting signaling pathways: B-cell receptor and beyond
Moderators
Discussants |
| 16:00 – 16:15 | Coffee break |
| 16:15 – 17:45 |
Workshops – Rotation B
Workshop I – Auditorium
Moderators Panagiotis Baliakas, Sarka Pospisilova Workshop II – Room A1 Immunoglobulin genes
Moderators Anastasia Chatzidimitriou, Frederic Davi Workshop III – Room A2–A3 MRD
Moderators Arnon Kater, Andy Rawstron Workshop IV – Room A4 The CLL patient path
Moderators Christina Karamanidou, Kostas Stamatopoulos Workshop V – Room South 9–10 How to be involved in ERIC real world studies
Moderators Tamar Tadmor, Andrea Visentin Workshop VI – Room South 11–12 How to implement current evidence for diagnostic work up and treatment of CLL into National guidelines
Moderators Daniela Alves, Carsten Utoft Niemann |
| 18:00 – 19:00 |
Poster walk
Moderators |
Day 3, Saturday, October 17
| 08.00 – 09.30 |
Workshops – Rotation C
Workshop I – Auditorium
Moderators Panagiotis Baliakas, Sarka Pospisilova
Workshop II – Room A1
Moderators Anastasia Chatzidimitriou, Frederic Davi
Workshop III – Room A2–A3
Moderators Arnon Kater, Andy Rawstron
Workshop IV – Room A4
Moderators Christina Karamanidou, Kostas Stamatopoulos
Workshop V – Room South 9–10
Moderators Tamar Tadmor, Andrea Visentin
Workshop VI – Room South 11–12
Moderators Daniela Alves, Carsten Utoft Niemann |
| 09:30 – 10:00 / Auditorium |
Discussion Biological profiling and clinical management of CLL: how far and how deep?
Moderator
Discussants |
| 10.00 – 11.00 / Auditorium |
Session V Assessing responses
Moderators
Discussants |
| 11.00 – 11.30 | Coffee break |
| 11.30 – 12.45 / Auditorium |
Session VI Richter’s transformation
Moderators
Discussants |
| 12.45 – 13.15 / Auditorium |
Plenary talk CLL: my vision for the future
Moderator
Speaker |
| 13.15 – 13.30 / Auditorium |
Closing remarks
Paolo Ghia |
Technical secretariat: +34 93 882 38 78 · eric2026@bcocongresos.com .


